What is Nexlizet?
Nexlizet is a prescription cholesterol-lowering medicine that combines bempedoic acid and ezetimibe. According to FDA labeling, it is used along with diet to lower LDL cholesterol in adults with primary hyperlipidemia, including heterozygous familial hypercholesterolemia. The bempedoic acid component is also labeled to help reduce the risk of heart attack and coronary revascularization in adults who cannot take recommended statin therapy and who have established cardiovascular disease or a high risk for cardiovascular disease. This article is for general education only and is not medical advice. ([accessdata.fda.gov](https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/211617s027s028lbl.pdf?utm_source=openai))
Who may be asked about Nexlizet by a clinician?
This medicine is most often discussed for adults who need additional LDL lowering or who have a reason they cannot use the statin therapies typically recommended first. It may also come up in people with familial hypercholesterolemia or in those who still need more LDL reduction despite other treatment plans. Because the best choice depends on medical history, a pharmacist or clinician should answer personal questions about whether Nexlizet fits a particular situation. ([accessdata.fda.gov](https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/211617s027s028lbl.pdf?utm_source=openai))
How is it taken?
FDA labeling says Nexlizet is taken once daily as one tablet by mouth, with or without food. The tablet should be swallowed whole. If it is used with a bile acid sequestrant, the label says to take Nexlizet at least 2 hours before or at least 4 hours after that medicine. The label also says lipid levels should be checked after treatment starts, typically within 8 to 12 weeks. Do not change a personal treatment plan without speaking with the prescribing clinician. ([accessdata.fda.gov](https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/211617s027s028lbl.pdf?utm_source=openai))
What are the main benefits?
The main expected benefit is LDL cholesterol lowering. For people who need extra LDL reduction, that can be clinically useful as part of a broader cardiovascular risk-reduction plan. The bempedoic acid component also has an FDA-approved cardiovascular outcomes indication in certain statin-intolerant adults with cardiovascular disease or high risk. The practical takeaway is that Nexlizet is a prescription option when lowering LDL remains important and statins are not enough or not a good fit. ([accessdata.fda.gov](https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/211617s027s028lbl.pdf?utm_source=openai))
What are the downsides or risks?
FDA labeling highlights several important safety issues. Nexlizet is contraindicated in people with a prior hypersensitivity to ezetimibe, bempedoic acid, or any ingredient in the product. The label warns about hyperuricemia and says uric acid should be assessed periodically when clinically indicated. It also warns about tendon rupture and says the drug should be stopped at the first sign of tendon rupture; people with a history of tendon disorders or tendon rupture should generally avoid it. The label also notes possible fetal harm based on mechanism, so pregnancy questions should be handled by a clinician. ([accessdata.fda.gov](https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/211617s027s028lbl.pdf?utm_source=openai))
What side effects are commonly discussed?
In labeling, commonly reported reactions include upper respiratory tract infection, muscle spasms, hyperuricemia, back pain, abdominal pain or discomfort, bronchitis, pain in an extremity, anemia, elevated liver enzymes, diarrhea, arthralgia, sinusitis, fatigue, and influenza-like symptoms. That does not mean a person will get these effects, but it does help set expectations. Any new or severe symptom should be discussed with a clinician. MedlinePlus also reminds patients that drug reactions and interactions can vary, and questions are best directed to a health care provider or pharmacist. ([accessdata.fda.gov](https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/211617s019lbl.pdf?utm_source=openai))
Common patient questions, answered simply
Is Nexlizet a statin?
No. It combines bempedoic acid and ezetimibe, so it works differently from a statin. That matters because some people use it when statins are not tolerated or not sufficient, but that decision belongs with a clinician. ([accessdata.fda.gov](https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/211617s027s028lbl.pdf?utm_source=openai))
Can it be used with other cholesterol medicines?
Yes, the label says it may be used alone or in combination with other LDL-lowering therapies. However, whether it should be paired with another medicine depends on the full medication list and the person’s risk factors. ([accessdata.fda.gov](https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/211617s027s028lbl.pdf?utm_source=openai))
What if a dose is missed?
FDA labeling says to take the missed dose as soon as possible, but not to double the next dose. If there is uncertainty, a pharmacist can help clarify safe timing. ([accessdata.fda.gov](https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/211617s027s028lbl.pdf?utm_source=openai))
What symptoms need urgent care?
Urgent medical attention is appropriate for possible severe allergic reaction, tendon injury symptoms, or other sudden serious symptoms. In particular, new tendon pain, swelling, or trouble moving a joint should not be ignored. Sudden facial swelling, trouble breathing, chest pain, or fainting are emergencies. ([accessdata.fda.gov](https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/211617s027s028lbl.pdf?utm_source=openai))
Practical steps before asking about Nexlizet
- Gather the medication list, including supplements and over-the-counter products.
- Note any history of gout, tendon injury, liver issues, pregnancy, or allergy.
- Write down the reason for the question, such as side effects, timing with other medicines, or whether it is appropriate at all.
- Ask a pharmacist or clinician to interpret the label in the context of the person’s health history.
These steps help make the conversation more useful and reduce the risk of missed interactions or safety issues. ([accessdata.fda.gov](https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/211617s027s028lbl.pdf?utm_source=openai))
Alternatives to discuss with a clinician
Possible alternatives depend on the goal. Other LDL-lowering therapies may include statins, ezetimibe alone, and other prescription options chosen based on cardiovascular risk, prior response, and tolerance. The right option is individualized, so a general article cannot pick one treatment over another. The FDA label and the patient’s own history should guide the conversation. ([accessdata.fda.gov](https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/211617s027s028lbl.pdf?utm_source=openai))
Concise decision checklist
- Is the question about LDL lowering, a side effect, or a drug interaction?
- Does the person have a history of gout, tendon problems, or allergy to the ingredients?
- Is the person pregnant, planning pregnancy, or breastfeeding?
- Is Nexlizet being considered alongside other cholesterol medicines or a bile acid sequestrant?
- Has a pharmacist or clinician reviewed the full medication list and answered the personal question?
Bottom line: Nexlizet is a prescription option for lowering LDL cholesterol, and it can play a role in certain adults who need additional treatment or cannot use statins. Its benefits and risks are best judged in context, which is why personal questions should go to a clinician or pharmacist. Urgent symptoms require immediate medical care. ([accessdata.fda.gov](https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/211617s027s028lbl.pdf?utm_source=openai))
Frequently Asked Questions
FAQ
What is Nexlizet used for?
It is used with diet to lower LDL cholesterol in adults with primary hyperlipidemia, including heterozygous familial hypercholesterolemia. The bempedoic acid component also has a cardiovascular risk-reduction indication in certain adults who cannot take recommended statins. ([accessdata.fda.gov](https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/211617s027s028lbl.pdf?utm_source=openai))
Is Nexlizet safe for everyone?
No. It is not for people with hypersensitivity to bempedoic acid, ezetimibe, or any ingredient in the product. The label also warns about hyperuricemia, tendon rupture, and possible fetal harm. ([accessdata.fda.gov](https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/211617s027s028lbl.pdf?utm_source=openai))
Can I take it with other cholesterol medicines?
Sometimes, yes. FDA labeling says it may be used alone or with other LDL-lowering therapies, but that should be decided with a clinician who knows the full medical history. ([accessdata.fda.gov](https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/211617s027s028lbl.pdf?utm_source=openai))
What should I do if I have a question about my own prescription?
Ask the prescribing clinician or a pharmacist. They can review the medicine list, safety concerns, and timing with other drugs. For urgent symptoms, seek immediate medical care. ([medlineplus.gov](https://medlineplus.gov/drugreactions.html?utm_source=openai))
Sources and Further Reading
- www.accessdata.fda.gov
- www.accessdata.fda.gov
- medlineplus.gov
- www.accessdata.fda.gov
- www.accessdata.fda.gov
Editorial note: This article was prepared using live web research and public sources. Policies, prices, availability, health information, and platform interfaces may change. Verify important details with the relevant official source.
Featured image: question, questions, full hd wallpaper, question marks, desktop backgrounds, hd wallpaper, free background, single, background, free wallpaper, 3d wallpapers, wallpaper 4k, wallpaper hd, beautiful wallpaper, wallpaper, mac wallpaper, 4k wallpaper, cool backgrounds, problem, ask, windows wallpaper, faq, laptop wallpaper, help, punctuation mark, 4k wallpaper 1920×1080, 3d by BlenderTimer (Pixabay Content License).
About The Author
